Lupron, a model title for leuprolide acetate, features as a gonadotropin-releasing hormone (GnRH) agonist. Within the context of a frozen embryo switch (FET) cycle, its main position is to suppress the physique’s pure hormonal manufacturing. By downregulating the pituitary gland, Lupron prevents untimely ovulation, which is essential for exactly controlling the timing of the endometrial lining improvement and embryo implantation.
Using a GnRH agonist offers clinicians with enhanced management over the menstrual cycle throughout an FET. This managed method permits for optimum synchronization between the embryo’s developmental stage and the uterine lining’s receptivity. Traditionally, attaining this synchronization introduced a big problem in assisted reproductive applied sciences. The managed surroundings created by means of hormonal suppression maximizes the probability of profitable implantation and subsequent being pregnant.
